VPRIV

This brand name is authorized in United States. It is also authorized in Austria, Brazil, Canada, Croatia, Cyprus, Estonia, Finland, France, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Spain, Turkey, UK.

Active ingredients

The drug VPRIV contains one active pharmaceutical ingredient (API):

1	Velaglucerase alfa UNII 23HYE36B0I - VELAGLUCERASE ALFA
	Velaglucerase alfa supplements or replaces beta-glucocerebrosidase, the enzyme that catalyzes the hydrolysis of glucocerebroside to glucose and ceramide in the lysosome, reducing the amount of accumulated glucocerebroside and correcting the pathophysiology of Gaucher disease. Velaglucerase alfa increases haemoglobin concentration and platelet counts and reduces liver and spleen volumes in patients with type 1 Gaucher disease.
	Read more about Velaglucerase alfa

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
VPRIV Powder for solution for infusion	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A16AB10	Velaglucerase alfa	A Alimentary tract and metabolism → A16 Other alimentary tract and metabolism products → A16A Other alimentary tract and metabolism products → A16AB Enzymes
Discover more medicines within A16AB10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	501121020037817
CA	Health Products and Food Branch	02357119
EE	Ravimiamet	1492040, 1588473, 1588484
ES	Centro de información online de medicamentos de la AEMPS	10646002
FI	Lääkealan turvallisuus- ja kehittämiskeskus	103528
FR	Base de données publique des médicaments	65369582
GB	Medicines & Healthcare Products Regulatory Agency	182451
IL	מִשְׂרַד הַבְּרִיאוּת	6707
IT	Agenzia del Farmaco	040424018, 040424020
JP	医薬品医療機器総合機構	3959416F1020
LT	Valstybinė vaistų kontrolės tarnyba	1056324, 1061958, 1061959
NL	Z-Index G-Standaard, PRK	91618
NZ	Medicines and Medical Devices Safety Authority	17445
PL	Rejestru Produktów Leczniczych	100235510
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W68150001
TR	İlaç ve Tıbbi Cihaz Kurumu	8699943790073, 8699943790080, 8699943790097
US	FDA, National Drug Code	54092-701